1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > Cancer Drug News 01 JUNE 2015

Cancer Drug News 01 JUNE 2015

  • June 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Biologics Focus To Continue Driving In-House Biomanufacturing Investment
Industry Brief - Imbruvica Gains CHMP Positive Opinion In WM
Industry Brief - Masitinib Phase II Trial In r/r PTCL Accelerates Into Phase III
Industry Brief - Sophiris Enrols First Patients In Phase IIa PoC Trial Of PRX302
Industry Brief - Innocrin Begins VT-464 Phase II CRPCA Study
Industry Brief - Enzalutamide Phase II Trial Meets Primary Endpoint In Metastatic/Non-Metastatic PCA
Industry Brief - FDA Grants ODD To Cerulean's CRLX101 For OC
Industry Trend Analysis - T-VEC Set To Become First Western Viral Immunotherapy
Industry Brief - FDA Accepts sBLA For Opdivo+Yervoy In Untreated Advanced Melanoma
Industry Brief - EC Grants Approval For Eisai's Lenvima
Industry Brief - Regeneus To Start Personalised Human Cancer Vaccine Trial
Industry Trend Analysis - Juno Creating CAR-T Powerhouse
Industry Brief - Eureka/BI Collaborate To Develop Abs In Oncology
Industry Trend Analysis - Keytruda Companion Diagnostic Will Not Keep Roche At Bay
Industry Brief - AstraZeneca/Lilly Enter Immuno-Oncology Clinical Trial Collaboration
Industry Brief - Ono Seeks Japanese Additional Approval For Proemend In CINV
Industry Brief - Aloxi Gains EU Approval For CINV Prevention In Infants
Industry Brief - AbbVie Completes Pharmacyclics Acquisition
Industry Brief - Baxter Ventures/Mayo Clinic/VPD Form Vitesse Biologics
Industry Trend Analysis - Transposagen Spin-Out Prime Acquisition Target

Table Of Contents

Cancer Drug News 01 JUNE 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2016 Competing in the Global Cancer Diagnostics Market

2016 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.